Hans Chulhee Lee

12.7k citations
296 papers · 9.5k · 5 hit papers · h-index 47

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
  • Oncology top 0.5%
    • CAR-T cell therapy research
    • Drug Transport and Resistance Mechanisms
    • Cancer Immunotherapy and Biomarkers
    • Peptidase Inhibition and Analysis

Papers in

    • Multiple Myeloma Research and Treatments 148
    • Peptidase Inhibition and Analysis 27
    • Cancer Treatment and Pharmacology 15

Hans Chulhee Lee

279 papers receiving 9.2k citations

Hans Chulhee Lee's Hit Papers

Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma 2024 · 97 citations
970+6+13Years since publication250500750

Peers

Hans Chulhee Lee
Comparison fields: 5 of 172
  • Hematology 2.1k
  • Oncology 3.2k
  • Genetics 491
  • Molecular Biology 3.1k
  • Pulmonary and Respiratory Medicine 1.2k
Replace Thomas L. Force with:
Thomas L. Force United States
Jorge Nieva United States
Linda T. Vahdat United States
William D. Figg United States
Zhengjia Chen United States
Brian Matthew Wolpin United States
Michael Joe Duffy Ireland
Роберто Пили United States
Tetsuji Takayama Japan
Patrick J. Flynn United States
Hans Chulhee Lee relative to Thomas L. Force United States Thomas L. Force's profile →
Citations per field
00.5×2×2.7×
Thomas L. Force · 1×
Citations per year

Countries citing papers authored by Hans Chulhee Lee

Since Specialization
Citations

This map shows the geographic impact of Hans Chulhee Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Chulhee Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Chulhee Lee more than expected).

Fields of papers citing papers by Hans Chulhee Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Chulhee Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Chulhee Lee. The network helps show where Hans Chulhee Lee may publish in the future.

Co-authors

The 25 scholars most cited alongside Hans Chulhee Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans Chulhee Lee Line = papers co-authored together Hans Chulhee Lee links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 296 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Hit paper breakdown →
2006826
2
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
Hit paper breakdown →
2019637
3
Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas
Hit paper breakdown →
2020480
4
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis
Hit paper breakdown →
2021448
5 2018343
6 2006298
7 2000261
8 1999221
9 2000198
10 2017182
11 2002166
12 2016166
13 2020153
14 2006148
15 2019144
16 2005142
17 2018139
18 2004130
19 2021122
20 2019115

About Hans Chulhee Lee

Hans Chulhee Lee is a scholar working on Hematology, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 296 papers that have together received 9.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (148 papers), Protein Degradation and Inhibitors (60 papers), Peptidase Inhibition and Analysis (27 papers), Lung Cancer Diagnosis and Treatment (25 papers), Chronic Lymphocytic Leukemia Research (21 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (16 papers), Cancer Treatment and Pharmacology (15 papers) and Pleural and Pulmonary Diseases (15 papers). The work is most often cited by research in Hematology (2.1k citations), Oncology (3.2k citations), Genetics (491 citations), Molecular Biology (3.1k citations) and Pulmonary and Respiratory Medicine (1.2k citations). Hans Chulhee Lee has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Peter A. Edwards, Yanqiao Zhang, Frank J. Gonzalez, Timothy Mark Willson, Gabriel Barrera, M. Frederick Hawthorne, Judith A. Berliner, Florence Y. Lee, Carolyn B. Knobler and Ganesamoorthy Subbanagounder. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, CHEST Journal, Blood Cancer Journal and American Journal of Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact